A peptide stack is a combination of two or more peptides or peptide-adjacent products marketed together for a goal such as injury recovery, body composition, focus, skin appearance, libido, or longevity. Stacks are popular in biohacking communities, but popularity is not approval, proof, or safety.
Most stacks are sold around synergy: one peptide is said to start a signal, another to amplify it, and another to fill a gap. That framing can be useful, but it can also make weak evidence sound precise.
A stack can contain one approved medicine, one cosmetic ingredient, one supplement, and one research chemical. Evidence for one component does not transfer to the combination.
The strongest evidence would test the exact combination, finished product, route, population, and outcome. Most wellness-market stacks do not have that kind of evidence.
A topical cosmetic stack, an oral supplement stack, a prescription medication combination, and a research-use injectable stack are different safety situations.
Injectable stacks raise the highest quality concerns: sterility, concentration, impurities, storage, immune reactions, and whether anyone is monitoring adverse effects.
Even if each component has a plausible mechanism, combining them can create additive side effects, interactions, overlapping contraindications, and confusing signals if something goes wrong.
For athletes, anti-doping rules can be stricter than consumer law. A substance can be popular online and still be prohibited in sport.
This list focuses on combinations people commonly encounter online. It is not a recommendation and it is not a complete protocol library.
| Stack | Common components | Marketed goal | Key caution |
|---|---|---|---|
| Wolverine Stack | BPC-157 + TB-500 | Marketed for tendon, ligament, muscle, joint, cartilage, and post-injury recovery. | The major issues are unknown human safety, product identity, sterility, immune reactions, impurities, unclear concentration, and the temptation to inject around injuries without diagnosis. |
| Growth Hormone Secretagogue Stack | CJC-1295 + Ipamorelin | Promoted for sleep quality, recovery, body composition, training adaptation, and anti-aging. | Risk questions include glucose changes, edema, carpal-tunnel-like symptoms, endocrine disruption, cardiovascular symptoms, cancer history, sleep apnea, and whether the product is a regulated medicine or a research-use vial. |
| Focus and Calm Stack | Semax + Selank | Marketed for focus, mood, stress resilience, anxiety support, and cognitive performance. | Watch for neurologic or mood effects, interactions with psychiatric medications, sleep disruption, overconfident productivity claims, and nasal products with unclear absorption or preservative quality. |
| Metabolic Incretin Stack | GLP-1 medicine + amylin or amylin-like agent | Discussed for appetite regulation, weight management, satiety, and metabolic disease treatment. | Risks include nausea, vomiting, dehydration, gallbladder issues, pancreatitis warnings, hypoglycemia risk when combined with diabetes medicines, dosing errors, and unsafe compounded or gray-market versions. |
| Compounded GLP-1 Add-On Stack | Semaglutide or tirzepatide + B12, B6, L-carnitine, NAD, or similar add-ons | Marketed for weight loss with added energy, nausea support, metabolism, or wellness benefits. | The concerns are concentration variability, multi-dose vial measurement errors, salt forms, shipping and refrigeration problems, extra ingredients, side effects from GLP-1 drugs, and misleading claims that imply compounded products are the same as approved products. |
| Skin and Collagen Support Stack | Topical GHK-Cu + palmitoyl peptides + collagen peptides | Promoted for skin texture, hydration, barrier feel, fine-line appearance, and connective-tissue support. | Lower-risk does not mean no-risk. |
| Glow and Repair Research Stack | GHK-Cu + BPC-157, sometimes with TB-500 | Marketed for skin repair, hair appearance, wound healing, recovery, and anti-aging. | The biggest risk is route confusion: topical skin-care use is not the same as injecting research peptides. |
| Libido and Tanning Stack | Bremelanotide / PT-141 + Melanotan II | Promoted for libido, sexual response, tanning, and appearance-focused body confidence. | Risks include blood pressure effects, nausea, flushing, darkening of moles or pigmentation changes, sexual side effects, counterfeit products, and missing a diagnosis for sexual dysfunction or skin changes. |
| Sleep and Longevity Stack | DSIP + Epitalon | Marketed for sleep quality, circadian rhythm, stress recovery, telomeres, and longevity. | Risk questions include next-day fatigue, mood changes, endocrine effects, interaction with sleep disorders, false reassurance around aging claims, and use of research chemicals without safety monitoring. |
| Immune and Inflammation Research Stack | Thymosin alpha-1 + KPV or LL-37 | Promoted for immune balance, inflammation, gut symptoms, infection resilience, and recovery. | Risks include immune overactivation or suppression, masking infection, interactions with autoimmune disease or immunosuppressive drugs, peptide impurities, and confusing antimicrobial research with approved anti-infective treatment. |
| Fat-Loss Research Stack | AOD-9604 + MOTS-c, sometimes with GLP-1 products | Marketed for fat metabolism, mitochondrial health, exercise adaptation, and body recomposition. | Risks include unproven benefit, immune reactions, impurities, glucose or appetite changes, misleading body-composition claims, and layering unapproved products onto already potent metabolic medicines. |
| Sermorelin Secretagogue Stack | Sermorelin + GHRP-2 or GHRP-6 | Marketed for growth-hormone support, sleep, recovery, lean mass, and anti-aging clinic programs. | Risks include endocrine disruption, glucose changes, edema, carpal-tunnel-like symptoms, appetite changes, sleep apnea concerns, cancer-history questions, and confusion between legitimate endocrine care and anti-aging marketing. |
| Hexarelin Performance Stack | Hexarelin + CJC-1295 | Promoted for strength, recovery, training adaptation, body composition, and growth-hormone signaling. | Risks include excessive endocrine stimulation, fluid retention, glucose effects, blood-pressure or cardiovascular symptoms, prolactin or cortisol concerns, injection quality issues, and anti-doping problems for athletes. |
| Tesamorelin Body-Composition Stack | Tesamorelin + GLP-1 product | Discussed for abdominal fat, appetite control, metabolic health, and clinic-led body-composition programs. | Risks include glucose changes, nausea, dehydration, gallbladder concerns, injection burden, contraindication overlap, off-label drift, and missing the difference between specialist treatment and broad wellness use. |
| Mitochondrial Longevity Stack | MOTS-c + Epitalon | Marketed for mitochondrial health, cellular energy, exercise resilience, aging, and healthspan. | Risks include unknown long-term biology, immune reactions, impurities, endocrine or sleep effects, false reassurance around aging claims, and delaying better-established metabolic or sleep care. |
| Gut Barrier Research Stack | BPC-157 + KPV | Promoted for gut lining support, inflammation, food tolerance, bloating, and recovery from digestive irritation. | Risks include masking inflammatory bowel disease, infection, bleeding, medication side effects, or food allergy; using research vials orally or by injection without oversight; and trusting symptom anecdotes over diagnosis. |
| Hair and Skin Copper Stack | GHK-Cu + TB-500 + Collagen peptides | Marketed for hair appearance, skin texture, wound recovery, connective-tissue support, and cosmetic anti-aging. | Risks include irritation, allergy, supplement quality issues, research-peptide sterility concerns, unrealistic hair-regrowth claims, and missing medical causes of hair loss or poor wound healing. |
| Libido and Bonding Stack | Bremelanotide + Oxytocin | Marketed for libido, arousal, emotional closeness, relationship bonding, and sexual confidence. | Risks include nausea, flushing, blood-pressure effects, uterine effects, psychiatric or relationship-context concerns, missed diagnoses for sexual dysfunction, and using hormones or neuropeptides to bypass appropriate care. |
| Fertility Signal Stack | Kisspeptin + Gonadorelin | Discussed around reproductive hormones, LH and FSH signaling, fertility optimization, and hormone-axis testing. | Risks include cycle disruption, ovarian or testicular hormone changes, missed infertility diagnoses, pregnancy-related concerns, medication interactions, and confusing monitoring-heavy reproductive medicine with wellness optimization. |
| Respiratory Recovery Research Stack | Aviptadil + Thymosin alpha-1 | Promoted for lung recovery, immune resilience, inflammation control, and post-viral wellness. | Risks include delaying evaluation for asthma, pneumonia, pulmonary embolism, long COVID, autoimmune disease, or infection; immune effects; product-quality problems; and relying on symptom claims without objective monitoring. |
| Clinic Anti-Aging Bundle | Sermorelin + Epitalon + NAD add-ons | Marketed for vitality, recovery, sleep, hormone support, cellular repair, and longevity. | Risks include cost without clear benefit, endocrine side effects, sleep or mood changes, supplement or infusion add-on risks, over-testing, and replacing ordinary medical prevention with a proprietary bundle. |
Open a detailed page for the component links, evidence lens, product-quality questions, red flags, and source checks for each stack.
BPC-157 + TB-500
Marketed for tendon, ligament, muscle, joint, cartilage, and post-injury recovery.
CJC-1295 + Ipamorelin
Promoted for sleep quality, recovery, body composition, training adaptation, and anti-aging.
Semax + Selank
Marketed for focus, mood, stress resilience, anxiety support, and cognitive performance.
GLP-1 medicine + amylin or amylin-like agent
Discussed for appetite regulation, weight management, satiety, and metabolic disease treatment.
Semaglutide or tirzepatide + B12, B6, L-carnitine, NAD, or similar add-ons
Marketed for weight loss with added energy, nausea support, metabolism, or wellness benefits.
Topical GHK-Cu + palmitoyl peptides + collagen peptides
Promoted for skin texture, hydration, barrier feel, fine-line appearance, and connective-tissue support.
GHK-Cu + BPC-157, sometimes with TB-500
Marketed for skin repair, hair appearance, wound healing, recovery, and anti-aging.
Bremelanotide / PT-141 + Melanotan II
Promoted for libido, sexual response, tanning, and appearance-focused body confidence.
DSIP + Epitalon
Marketed for sleep quality, circadian rhythm, stress recovery, telomeres, and longevity.
Thymosin alpha-1 + KPV or LL-37
Promoted for immune balance, inflammation, gut symptoms, infection resilience, and recovery.
AOD-9604 + MOTS-c, sometimes with GLP-1 products
Marketed for fat metabolism, mitochondrial health, exercise adaptation, and body recomposition.
Sermorelin + GHRP-2 or GHRP-6
Marketed for growth-hormone support, sleep, recovery, lean mass, and anti-aging clinic programs.
Hexarelin + CJC-1295
Promoted for strength, recovery, training adaptation, body composition, and growth-hormone signaling.
Tesamorelin + GLP-1 product
Discussed for abdominal fat, appetite control, metabolic health, and clinic-led body-composition programs.
MOTS-c + Epitalon
Marketed for mitochondrial health, cellular energy, exercise resilience, aging, and healthspan.
BPC-157 + KPV
Promoted for gut lining support, inflammation, food tolerance, bloating, and recovery from digestive irritation.
GHK-Cu + TB-500 + Collagen peptides
Marketed for hair appearance, skin texture, wound recovery, connective-tissue support, and cosmetic anti-aging.
Bremelanotide + Oxytocin
Marketed for libido, arousal, emotional closeness, relationship bonding, and sexual confidence.
Kisspeptin + Gonadorelin
Discussed around reproductive hormones, LH and FSH signaling, fertility optimization, and hormone-axis testing.
Aviptadil + Thymosin alpha-1
Promoted for lung recovery, immune resilience, inflammation control, and post-viral wellness.
Sermorelin + Epitalon + NAD add-ons
Marketed for vitality, recovery, sleep, hormone support, cellular repair, and longevity.
Before trusting stack marketing, compare it against regulatory and clinical sources. FDA materials are especially useful for compounded-product risk, GLP-1 concerns, and bulk-substance safety flags.
